News Featured Nov 14, 2024 Therakind receives grant award from Innovate UK Nov 14, 2024 Read More → Nov 14, 2024 Nov 1, 2024 Therakind Sponsors Drug Delivery to Lung Forum 2024 Nov 1, 2024 Read More → Nov 1, 2024 Oct 14, 2024 Therakind is attending BIO Europe 2024 Oct 14, 2024 Read More → Oct 14, 2024 Sep 23, 2024 Therakind Presents a Poster at the 3rd Annual Inhaled & Nasal Biologics Forum 2024 Sep 23, 2024 Read More → Sep 23, 2024 May 30, 2024 Oresund Pharma acquires the international rights outside the US for Therakind’s oncology and autoimmune product, Jylamvo® May 30, 2024 Read More → May 30, 2024 May 27, 2024 US patent granted for Therakind’s DriDose® multi-dose delivery system May 27, 2024 Read More → May 27, 2024 May 22, 2024 Therakind is attending BIO 2024 May 22, 2024 Read More → May 22, 2024 Mar 25, 2024 Therakind completes Management Buy-Out Mar 25, 2024 Read More → Mar 25, 2024 Nov 30, 2023 Therakind Sponsors DDL 2023 Nov 30, 2023 Read More → Nov 30, 2023 Oct 31, 2023 Shorla Oncology Announces US Acquisition of Jylamvo, an Oncology and Autoimmune Drug from Therakind Oct 31, 2023 Read More → Oct 31, 2023 Mar 28, 2023 Therakind’s DriDose® Dry Powder Intranasal Device Delivers Vaccine Mar 28, 2023 Read More → Mar 28, 2023 May 12, 2022 Therakind enters exclusive distribution partnership with Oresund Pharma May 12, 2022 Read More → May 12, 2022 Aug 9, 2021 Therakind collaborates with Indosys to develop a novel dry powder nasal device Aug 9, 2021 Development of a new drug delivery platform Read More → Aug 9, 2021 Dec 2, 2020 Brazilian patent granted for Therakind novel dry powder nasal device DriDose® Dec 2, 2020 Brazil patent granted for Therakind novel dry powder nasal device DriDose® Read More → Dec 2, 2020 Sep 1, 2020 Therakind acquires IP to novel dry powder nasal device, DriDose® Sep 1, 2020 DriDose® to form basis of Therakind novel delivery platform Read More → Sep 1, 2020 Sep 1, 2020 Therakind acquires IP to novel dry powder nasal device, DriDose® Sep 1, 2020 DriDose® to form basis of Therakind novel delivery platform Read More → Sep 1, 2020 Jun 1, 2020 Therakind attends Digital BIO 2020 Jun 1, 2020 Therakind attends Digital BIO 2020 Read More → Jun 1, 2020 Mar 14, 2020 Therakind enters exclusive distribution partnership with BioJam Holding Group Mar 14, 2020 Launch of Jylamvo in Portugal Read More → Mar 14, 2020 Jan 9, 2020 Therakind enters exclusive distribution partnership with Pharmalink Jan 9, 2020 Jylamvo targets United Arab Emirates market Read More → Jan 9, 2020
